DE60106048D1 - Matrix metalloproteinase inhibitoren - Google Patents
Matrix metalloproteinase inhibitorenInfo
- Publication number
- DE60106048D1 DE60106048D1 DE60106048T DE60106048T DE60106048D1 DE 60106048 D1 DE60106048 D1 DE 60106048D1 DE 60106048 T DE60106048 T DE 60106048T DE 60106048 T DE60106048 T DE 60106048T DE 60106048 D1 DE60106048 D1 DE 60106048D1
- Authority
- DE
- Germany
- Prior art keywords
- optionally substituted
- unsaturated
- hydrogen
- saturated
- bond
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003771 matrix metalloproteinase inhibitor Substances 0.000 title 1
- 229940121386 matrix metalloproteinase inhibitor Drugs 0.000 title 1
- 239000004215 Carbon black (E152) Substances 0.000 abstract 5
- 229930195733 hydrocarbon Natural products 0.000 abstract 5
- 229910052739 hydrogen Inorganic materials 0.000 abstract 5
- 239000001257 hydrogen Substances 0.000 abstract 5
- 229920006395 saturated elastomer Polymers 0.000 abstract 4
- -1 acetylthiomethyl group Chemical group 0.000 abstract 3
- 150000002431 hydrogen Chemical group 0.000 abstract 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 abstract 2
- 150000001335 aliphatic alkanes Chemical class 0.000 abstract 2
- 150000001336 alkenes Chemical class 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000004122 cyclic group Chemical group 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical group 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 229910052760 oxygen Inorganic materials 0.000 abstract 2
- 229910052717 sulfur Inorganic materials 0.000 abstract 2
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 abstract 1
- NEAQRZUHTPSBBM-UHFFFAOYSA-N 2-hydroxy-3,3-dimethyl-7-nitro-4h-isoquinolin-1-one Chemical group C1=C([N+]([O-])=O)C=C2C(=O)N(O)C(C)(C)CC2=C1 NEAQRZUHTPSBBM-UHFFFAOYSA-N 0.000 abstract 1
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 abstract 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 abstract 1
- 239000005977 Ethylene Substances 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 108091008648 NR7C Proteins 0.000 abstract 1
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical compound OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000001412 amines Chemical class 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6581—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms
- C07F9/6584—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms having one phosphorus atom as ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6581—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms
- C07F9/6584—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms having one phosphorus atom as ring hetero atom
- C07F9/65842—Cyclic amide derivatives of acids of phosphorus, in which one nitrogen atom belongs to the ring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Toxicology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21903100P | 2000-07-18 | 2000-07-18 | |
| US219031P | 2000-07-18 | ||
| PCT/DK2001/000464 WO2002006293A1 (en) | 2000-07-18 | 2001-07-03 | Matrix metalloproteinase inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE60106048D1 true DE60106048D1 (de) | 2004-11-04 |
| DE60106048T2 DE60106048T2 (de) | 2006-02-09 |
Family
ID=22817531
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60106048T Expired - Fee Related DE60106048T2 (de) | 2000-07-18 | 2001-07-03 | Matrix metalloproteinase inhibitoren |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US6521606B2 (de) |
| EP (1) | EP1303527B1 (de) |
| JP (1) | JP2004504326A (de) |
| KR (1) | KR20030018053A (de) |
| CN (1) | CN1443190A (de) |
| AT (1) | ATE277938T1 (de) |
| AU (2) | AU7047901A (de) |
| BR (1) | BR0112558A (de) |
| CA (1) | CA2416015A1 (de) |
| DE (1) | DE60106048T2 (de) |
| DK (1) | DK1303527T3 (de) |
| ES (1) | ES2228906T3 (de) |
| HU (1) | HUP0302904A3 (de) |
| IL (1) | IL153563A0 (de) |
| MX (1) | MXPA03000277A (de) |
| PL (1) | PL360371A1 (de) |
| PT (1) | PT1303527E (de) |
| RU (1) | RU2270835C2 (de) |
| SI (1) | SI1303527T1 (de) |
| WO (1) | WO2002006293A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050042194A1 (en) | 2000-05-11 | 2005-02-24 | A.P. Pharma, Inc. | Semi-solid delivery vehicle and pharmaceutical compositions |
| CN1714096A (zh) * | 2002-01-18 | 2005-12-28 | 利奥制药有限公司 | Mmp抑制剂 |
| CN1732023A (zh) * | 2002-12-27 | 2006-02-08 | 血管技术国际股份公司 | 组合物和使用collajolie的方法 |
| AU2003300076C1 (en) | 2002-12-30 | 2010-03-04 | Angiotech International Ag | Drug delivery from rapid gelling polymer composition |
| US8153804B2 (en) * | 2005-08-02 | 2012-04-10 | Lexicon Pharmaceuticals, Inc. | Aryl pyridines and methods of their use |
| WO2008122115A1 (en) * | 2007-04-09 | 2008-10-16 | Methylgene Inc. | Inhibitors of histone deacetylase |
| AU2015217221A1 (en) | 2014-02-13 | 2016-08-11 | Ligand Pharmaceuticals, Inc. | Prodrug compounds and their uses |
| EP3737676B1 (de) | 2018-01-09 | 2024-03-06 | Ligand Pharmaceuticals, Inc. | Acetalverbindungen und therapeutische verwendungen davon |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3732340A (en) * | 1966-07-11 | 1973-05-08 | Asta Werke Ag Chem Fab | N',o-propylene phosphoric acid ester diamides |
| US4618692A (en) * | 1981-09-03 | 1986-10-21 | Asta-Werke Aktiengesellschaft | 4-carbamoyloxy-oxazaphosphorins |
| FR2567129B1 (fr) * | 1984-07-06 | 1986-12-05 | Adir | Nouveaux derives de l'oxaazaphosphorine, leur procede de preparation et les compositions pharmaceutiques les renfermant |
| PL140732B1 (en) * | 1984-07-31 | 1987-05-30 | Polska Akad Nauk Centrum | Method of obtaining 2-/2-halogenethylamino/-2-oxo-3-/2-halogenethylo/-1,3,2-oxazophosphorianytes |
| AU2092597A (en) * | 1996-03-07 | 1997-09-22 | Novartis Ag | Antiproliferative combinations, containing raf-targeted oligonucleotides and chemotherapeutic compounds |
| CA2264254C (en) * | 1996-08-28 | 2003-03-11 | Yetunde Olabisi Taiwo | Phosphinic acid amides as matrix metalloprotease inhibitors |
| US6420586B1 (en) * | 2000-08-15 | 2002-07-16 | University Of Kansas | Amino acid-derived cyclic phosphonamides and methods of synthesizing the same |
-
2001
- 2001-07-03 KR KR10-2003-7000682A patent/KR20030018053A/ko not_active Application Discontinuation
- 2001-07-03 DE DE60106048T patent/DE60106048T2/de not_active Expired - Fee Related
- 2001-07-03 IL IL15356301A patent/IL153563A0/xx unknown
- 2001-07-03 PL PL36037101A patent/PL360371A1/xx not_active Application Discontinuation
- 2001-07-03 BR BR0112558-3A patent/BR0112558A/pt not_active Application Discontinuation
- 2001-07-03 MX MXPA03000277A patent/MXPA03000277A/es active IP Right Grant
- 2001-07-03 ES ES01949275T patent/ES2228906T3/es not_active Expired - Lifetime
- 2001-07-03 DK DK01949275T patent/DK1303527T3/da active
- 2001-07-03 PT PT01949275T patent/PT1303527E/pt unknown
- 2001-07-03 WO PCT/DK2001/000464 patent/WO2002006293A1/en active IP Right Grant
- 2001-07-03 JP JP2002512195A patent/JP2004504326A/ja active Pending
- 2001-07-03 AU AU7047901A patent/AU7047901A/xx active Pending
- 2001-07-03 RU RU2003104804/04A patent/RU2270835C2/ru not_active IP Right Cessation
- 2001-07-03 HU HU0302904A patent/HUP0302904A3/hu unknown
- 2001-07-03 AT AT01949275T patent/ATE277938T1/de not_active IP Right Cessation
- 2001-07-03 SI SI200130242T patent/SI1303527T1/xx unknown
- 2001-07-03 EP EP01949275A patent/EP1303527B1/de not_active Expired - Lifetime
- 2001-07-03 CN CN01812887A patent/CN1443190A/zh active Pending
- 2001-07-03 AU AU2001270479A patent/AU2001270479B2/en not_active Ceased
- 2001-07-03 CA CA002416015A patent/CA2416015A1/en not_active Abandoned
- 2001-07-06 US US09/899,017 patent/US6521606B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| PL360371A1 (en) | 2004-09-06 |
| EP1303527B1 (de) | 2004-09-29 |
| MXPA03000277A (es) | 2004-04-05 |
| JP2004504326A (ja) | 2004-02-12 |
| DE60106048T2 (de) | 2006-02-09 |
| WO2002006293A1 (en) | 2002-01-24 |
| PT1303527E (pt) | 2005-01-31 |
| EP1303527A1 (de) | 2003-04-23 |
| IL153563A0 (en) | 2003-07-06 |
| KR20030018053A (ko) | 2003-03-04 |
| ES2228906T3 (es) | 2005-04-16 |
| US20020103166A1 (en) | 2002-08-01 |
| CA2416015A1 (en) | 2002-01-24 |
| BR0112558A (pt) | 2003-07-22 |
| AU7047901A (en) | 2002-01-30 |
| US6521606B2 (en) | 2003-02-18 |
| SI1303527T1 (en) | 2005-04-30 |
| DK1303527T3 (da) | 2005-01-31 |
| AU2001270479B2 (en) | 2005-06-30 |
| HUP0302904A3 (en) | 2005-02-28 |
| ATE277938T1 (de) | 2004-10-15 |
| RU2270835C2 (ru) | 2006-02-27 |
| HUP0302904A2 (hu) | 2003-12-29 |
| CN1443190A (zh) | 2003-09-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR107616A1 (es) | Compuestos de 6,7-dihidro-5h-benzo[7]anuleno sustituidos, procesos para su preparación y usos terapéuticos de los mismos | |
| CO5180568A1 (es) | Compuestos farmaceuticos, especialmente mutilinas, composiciones farmaceuticas que los contienen | |
| AR067967A1 (es) | Un metodo para la reduccion de agua en un lodo de yeso y lodo de yeso | |
| PT88992A (pt) | Processo para a preparacao de compostos contendo fosforo uteis como inibidores de colagenase | |
| ATE277938T1 (de) | Matrix metalloproteinase inhibitoren | |
| UA122966C2 (uk) | Композиції з покращеним ефектом інгібування уреази, які містять триамід (тіо)фосфорної кислоти і додаткові сполуки, такі як аміни і барвники | |
| AR083953A1 (es) | Compuestos para tratar enfermedades neurodegenerativas | |
| BR112013030973A2 (pt) | processo para a preparação de amidas de prostaglandina | |
| ES2531084T3 (es) | Proceso para la preparación de 2-cianopirrolidinas n-sustituidas | |
| ES450995A1 (es) | Procedimiento para la obtencion de nuevos derivados de la amino-4-quinoleina. | |
| ATE233733T1 (de) | Benzamid derivate als thrombin-inhibitoren | |
| DE60220997D1 (de) | N-aryl-substituiertes cyclisches aminderivat und medizin, die dieses als wirkstoff enthält | |
| GB605268A (en) | Manufacture of combinations of agents for combating vermin | |
| ATE359273T1 (de) | Amonafidsalze | |
| BR0206982A (pt) | Composto, processo para a preparação do mesmo, uso de um composto, sistema adequado como um catalisador, e, processo para a carbonilação de compostos olefinicamente insaturados | |
| AR070737A1 (es) | Proceso para la elaboracion de (fenilsulfanilfenil) piperidinas | |
| PE20000418A1 (es) | Procedimiento para la preparacion de acidos hidroxamicos | |
| AR116626A1 (es) | Inhibidores de la ácido graso sintasa (fasn) | |
| GB1367663A (en) | Vulcanizable compositions containing cyclic o,o,s-triesters of phosphorodithioic acid | |
| AR122308A1 (es) | Nuevos compuestos heterocíclicos | |
| PL438052A1 (pl) | Pochodne fenotiazyny oraz ich zastosowanie | |
| GB956594A (en) | Bis-(ª-hydroxy-ª-arylaminoacetyl)-aryl derivatives | |
| ES207773A1 (es) | UN PROCEDIMIENTO PARA LA PREPARACIoN DE ANESTÉSICOS | |
| ES229980A1 (es) | Procedimiento de fabricación de una sustancia terapéutica | |
| GB641454A (en) | Tertiary amines and methods for obtaining the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |